Literature DB >> 25176971

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations.

Seiichiro Sakao1, Norbert F Voelkel2, Koichiro Tatsumi2.   

Abstract

The loss of pulmonary vessels has been shown to be related to the severity of pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD). The severity of hypoxaemia is also related to pulmonary hypertension and pulmonary vascular resistance in these patients, suggesting that the hypoxic condition probably plays an important role in this form of pulmonary hypertension. However, pulmonary hypertension also develops in patients with mild COPD without hypoxaemia. Oxygen supplementation therapy often fails to reverse the pulmonary hypertension in these COPD patients, thus suggesting that the pulmonary vascular alterations in those patients may involve different sites of the pulmonary vasculature or a different form of vascular remodelling. It has recently been demonstrated that pulmonary vascular remodelling, resulting in pulmonary hypertension in COPD patients, can develop independently from parenchymal destruction and loss of lung vessels. We wonder whether the changes in the lung microenvironment due to hypoxia and vessel loss have a causative role in the development of pulmonary hypertension in patients with COPD. Herein we review the pathobiological features of the pulmonary vasculature in COPD patients and suggest that pulmonary hypertension can occur with and without emphysematous lung tissue destruction and with and without loss of lung vessels. ©ERS 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25176971     DOI: 10.1183/09059180.00007913

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  30 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Authors:  Mary K Porteous; James C Lee; David J Lederer; Scott M Palmer; Edward Cantu; Rupal J Shah; Scarlett L Bellamy; Vibha N Lama; Sangeeta M Bhorade; Maria M Crespo; John F McDyer; Keith M Wille; A Russell Localio; Jonathan B Orens; Pali D Shah; Ann B Weinacker; Selim Arcasoy; David S Wilkes; Lorraine B Ware; Jason D Christie; Steven M Kawut; Joshua M Diamond
Journal:  Ann Am Thorac Soc       Date:  2017-10

Review 3.  The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.

Authors:  Vahid Mohsenin
Journal:  Sleep Breath       Date:  2016-05-07       Impact factor: 2.816

4.  Recruitment and effectiveness by cohort in a case management intervention among American Indians and Alaska Natives with diabetes.

Authors:  Katherine A Pratte; Janette Beals; Ann Johnson; Ann Bullock; Spero M Manson; Luohua Jiang
Journal:  Transl Behav Med       Date:  2019-07-16       Impact factor: 3.046

5.  Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.

Authors:  Yuji Yamamoto; Haruhiko Hirata; Takayuki Shiroyama; Tomoki Kuge; Kinnosuke Matsumoto; Midori Yoneda; Makoto Yamamoto; Yujiro Naito; Yasuhiko Suga; Kiyoharu Fukushima; Kotaro Miyake; Shohei Koyama; Kota Iwahori; Izumi Nagatomo; Yoshito Takeda; Atsushi Kumanogoh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-01

6.  Compromised Cardiopulmonary Function in Fibulin-5 Deficient Mice.

Authors:  Abhay B Ramachandra; Nicole Mikush; Maor Sauler; Jay D Humphrey; Edward P Manning
Journal:  J Biomech Eng       Date:  2022-08-01       Impact factor: 1.899

Review 7.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Authors:  Steven C Pugliese; Jens M Poth; Mehdi A Fini; Andrea Olschewski; Karim C El Kasmi; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

8.  HDAC6 Activates ERK in Airway and Pulmonary Vascular Remodeling of Chronic Obstructive Pulmonary Disease.

Authors:  Yunchao Su; Weihong Han; Anita Kovacs-Kasa; Alexander D Verin; Laszlo Kovacs
Journal:  Am J Respir Cell Mol Biol       Date:  2021-12       Impact factor: 6.914

9.  Management of Pulmonary Hypertension Due to Chronic Lung Disease.

Authors:  Jordan Sugarman; Jason Weatherald
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-07-01

10.  Vascular Pruning on CT and Interstitial Lung Abnormalities in the Framingham Heart Study.

Authors:  Andrew J Synn; Wenyuan Li; Gary M Hunninghake; George R Washko; Raúl San José Estépar; George T O'Connor; Cyrus A Kholdani; Robert W Hallowell; Alexander A Bankier; Murray A Mittleman; Mary B Rice
Journal:  Chest       Date:  2020-08-14       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.